nitroglycerin has been researched along with Dyslipidemias in 4 studies
Nitroglycerin: A volatile vasodilator which relieves ANGINA PECTORIS by stimulating GUANYLATE CYCLASE and lowering cytosolic calcium. It is also sometimes used for TOCOLYSIS and explosives.
nitroglycerol : A nitrate ester that is glycerol in which nitro group(s) replace the hydrogen(s) attached to one or more of the hydroxy groups.
nitroglycerin : A nitroglycerol that is glycerol in which the hydrogen atoms of all three hydroxy groups are replaced by nitro groups. It acts as a prodrug, releasing nitric oxide to open blood vessels and so alleviate heart pain.
Dyslipidemias: Abnormalities in the serum levels of LIPIDS, including overproduction or deficiency. Abnormal serum lipid profiles may include high total CHOLESTEROL, high TRIGLYCERIDES, low HIGH DENSITY LIPOPROTEIN CHOLESTEROL, and elevated LOW DENSITY LIPOPROTEIN CHOLESTEROL.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Rabbits with dyslipidemia were produced and randomly assigned into untreated, atorvastatin, nitroglycerin and combined groups (n=10 in each group)." | 7.83 | Atorvastatin Combined Nitroglycerin Therapy Confer Additive Effects on Rabbits with Dyslipidemia. ( Cui, L; Li, F; Wang, J; Yang, F, 2016) |
| "Rabbits with dyslipidemia were produced and randomly assigned into untreated, atorvastatin, nitroglycerin and combined groups (n=10 in each group)." | 3.83 | Atorvastatin Combined Nitroglycerin Therapy Confer Additive Effects on Rabbits with Dyslipidemia. ( Cui, L; Li, F; Wang, J; Yang, F, 2016) |
| "Treatment with fenofibrate significantly improved arterial endothelial function after 4 months." | 2.80 | Fenofibrate effects on arterial endothelial function in adults with type 2 diabetes mellitus: A FIELD substudy. ( Celermajer, DS; Harmer, JA; Keech, AC; Marwick, TH; Meredith, IT; Skilton, MR; Veillard, AS; Watts, GF, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harmer, JA | 1 |
| Keech, AC | 1 |
| Veillard, AS | 1 |
| Skilton, MR | 1 |
| Marwick, TH | 1 |
| Watts, GF | 2 |
| Meredith, IT | 1 |
| Celermajer, DS | 1 |
| Yang, F | 1 |
| Wang, J | 1 |
| Li, F | 1 |
| Cui, L | 1 |
| Chan, DC | 1 |
| Wong, AT | 1 |
| Yamashita, S | 1 |
| Lopes, FG | 1 |
| Bottino, DA | 1 |
| Oliveira, FJ | 1 |
| Mecenas, AS | 1 |
| Clapauch, R | 1 |
| Bouskela, E | 1 |
2 trials available for nitroglycerin and Dyslipidemias
| Article | Year |
|---|---|
Fenofibrate effects on arterial endothelial function in adults with type 2 diabetes mellitus: A FIELD substudy.
Topics: Aged; Australia; Brachial Artery; Diabetes Mellitus, Type 2; Double-Blind Method; Dyslipidemias; End | 2015 |
Apolipoprotein B-48 as a determinant of endothelial function in obese subjects with type 2 diabetes mellitus: effect of fenofibrate treatment.
Topics: Adult; Aged; Analysis of Variance; Apolipoprotein B-48; Apolipoprotein C-III; Brachial Artery; Chole | 2012 |
2 other studies available for nitroglycerin and Dyslipidemias
| Article | Year |
|---|---|
Atorvastatin Combined Nitroglycerin Therapy Confer Additive Effects on Rabbits with Dyslipidemia.
Topics: Animals; Atorvastatin; Disease Models, Animal; Drug Therapy, Combination; Dyslipidemias; Hydroxymeth | 2016 |
In elderly women moderate hypercholesterolemia is associated to endothelial and microcirculatory impairments.
Topics: Adult; Age Factors; Aged; Anthropometry; Blood Flow Velocity; Cholesterol; Cholesterol, LDL; Dyslipi | 2013 |